CIBC Asset Management Inc lifted its stake in McKesson Corporation (NYSE:MCK – Free Report) by 25.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 80,534 shares of the company’s stock after purchasing an additional 16,390 shares during the quarter. CIBC Asset Management Inc’s holdings in McKesson were worth $65,976,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of MCK. GGM Financials LLC purchased a new position in shares of McKesson in the 3rd quarter worth approximately $25,000. State of Wyoming purchased a new position in shares of McKesson in the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. purchased a new position in shares of McKesson in the 3rd quarter worth approximately $31,000. Vermillion & White Wealth Management Group LLC purchased a new position in shares of McKesson during the 3rd quarter worth about $33,000. Finally, Board of the Pension Protection Fund purchased a new position in shares of McKesson during the 4th quarter worth about $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.
Insider Activity
In other McKesson news, EVP Thomas L. Rodgers sold 2,388 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total value of $1,817,482.92. Following the completion of the sale, the executive vice president directly owned 3,090 shares in the company, valued at approximately $2,351,768.10. This represents a 43.59% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Michele Lau sold 3,550 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total value of $2,701,869.50. Following the completion of the sale, the executive vice president owned 3,247 shares of the company’s stock, valued at $2,471,259.23. This represents a 52.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.08% of the stock is owned by insiders.
Analysts Set New Price Targets
Check Out Our Latest Analysis on McKesson
McKesson Stock Up 0.1%
MCK opened at $735.76 on Wednesday. The business has a fifty day moving average of $816.69 and a 200 day moving average of $851.56. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00. The stock has a market cap of $88.44 billion, a P/E ratio of 19.13, a PEG ratio of 1.10 and a beta of 0.31.
McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.56 by $0.13. The company had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the previous year, the company earned $10.12 EPS. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Equities analysts anticipate that McKesson Corporation will post 44.29 EPS for the current fiscal year.
McKesson Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be given a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson’s payout ratio is 8.53%.
About McKesson
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Featured Stories
- Five stocks we like better than McKesson
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear CaseāIs a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
